Turkish community pharmacists’ behavioral determinants in provision of pharmaceutical care to elderly patients

Author(s):  
Betul Okuyan ◽  
Ecehan Balta ◽  
Vildan Ozcan ◽  
Ozge Durak Albayrak ◽  
Meltem Turker ◽  
...  
2013 ◽  
Vol 18 (5) ◽  
pp. 1721-1734 ◽  
Author(s):  
João Pelicano-Romano ◽  
Mariana R. Neves ◽  
Ana Amado ◽  
Afonso M. Cavaco

Author(s):  
Muhammed Yunus Bektay ◽  
Betul Okuyan ◽  
Mesut Sancar ◽  
Fikret Vehbi Izzettin

2016 ◽  
Vol 11 (1) ◽  
pp. 93-94 ◽  
Author(s):  
Win Myat Maw ◽  
Mi Mi Saw ◽  
Theingi Kyaw ◽  
Khin Ohnmar Kyaing ◽  
Zaw Min Latt ◽  
...  

Author(s):  
Azza Mohamed Tahir ◽  
Tarig Mohamed Hassan ◽  
Ali Awadallah Ali ◽  
Mazin Yousif Babiker ◽  
Mohamed Awad Mousnad

Introduction Pharmacists and pharmaceutical care services are among the most important tools in providing health services to the society. Pharmacists as the key players in presenting health services, critically impact on the health of the society and if they suffer low job satisfaction, their dissatisfaction may relatively threaten health in the society. This study was conducted to determine Sudanese community pharmacists’ job satisfaction and additionally, some causes of dissatisfaction among community pharmacists and their impact on providing pharmaceutical care services have been evaluated. Method The questionnaire was designed after reviewing relevant Literature in addition, The Job Satisfaction survey was used to measure the level of community pharmacists’ satisfaction with their current jobs, and the Toronto Alexithymia Scale (TAS-20) was used to evaluate emotional experience and awareness. Results and Discussion Generally low scores of job satisfaction were concluded among pharmacists while most of them were highly satisfied with being pharmacist. Conclusion Low levels of job satisfaction which were found among Sudanese community pharmacists could be considered as a deficiency of health system in Sudan. Fortunately, inherent interest in the pharmacy profession found among Sudanese pharmacists is an optimistic point at which policy-makers could develop their modifying policies. Health policy-makers must endeavor to take other steps to issue solutions for this current problem.


2020 ◽  
Vol 153 (5) ◽  
pp. 301-307
Author(s):  
Miranda Hambrook ◽  
Shaylee Peterson ◽  
Sean Gorman ◽  
Greg Becotte ◽  
Andrea Burrows

Background: Multiple medication changes during hospitalization increase the risk of errors upon discharge. Community pharmacists may face barriers to providing pharmaceutical care because of the lack of clinical information and communication from hospitals. Studies implementing handover to community pharmacists upon hospital discharge reported improved patient outcomes, but interventions were time-consuming. Methods: One-on-one interviews and a focus group were conducted to identify community pharmacists’ barriers to providing care to patients recently discharged from hospital and to determine their preferences for hospital discharge prescriptions. Transcripts were qualitatively analyzed using an inductive semantic approach. Results: Four one-on-one interviews and an 8-participant focus group were conducted. Participants described barriers to providing care to discharged patients, including lack of communication, incomplete prescriptions, and limited clinical information. Participants identified that the most valuable information to include comprised laboratory values, hospital contact information and annotation of medication changes. These items would improve their abilities to provide timely and high-quality pharmaceutical care. Interpretation: Our results were similar to prior literature identifying a lack of communication and clinical information as barriers to providing care to recently discharged patients. Unexpectedly, study participants did not rate medication indication as a strongly preferred information item. Conclusions: Hospital discharge prescriptions lack information, which makes it challenging for community pharmacists to provide pharmaceutical care. Discharge prescriptions should include additional clinical information. Can Pharm J (Ott) 2020;153:xx-xx.


1999 ◽  
Vol 39 (6) ◽  
pp. 843-856
Author(s):  
Rosemin Kassam ◽  
Karen B. Farris ◽  
Cheryl E. Cox ◽  
Carlyn I. Volume ◽  
Andrew Cave ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document